氧降和复氧速率对阻塞性睡眠呼吸暂停患者昼夜血压的影响

doi:10.13481/j.1671-587X.20210426

摘要/Abstract

摘要： 目的

探讨阻塞性睡眠呼吸暂停（OSA）患者睡眠中氧降速率和复氧速率对患者昼夜间血压的影响，并阐明其作用机制。

方法

收集106例OSA患者整夜多导睡眠呼吸监测资料，包括睡眠参数、呼吸事件参数和当天清醒期及睡眠期无创多点连续血压监测资料。根据OSA患者每个呼吸事件的氧降幅度与氧降时间的比值获得氧降速率，同样方法获得复氧速率。根据血压监测结果将患者分为OSA并发高血压组（OSA+HT组，59例）和OSA未并发高血压组（OSA－HT组，47例），分析2组患者氧降速率和复氧速率的差异，分别对所有入组患者进行氧降和复氧速率与白天血压值、夜间血压值以及夜间血压波动性（NBPF）的相关性分析。

结果

OSA+HT组患者氧降速率和复氧速率明显高于OSA－HT组（P<0.01）。氧降速率与患者夜间收缩压、舒张压、平均动脉压及白天舒张压和平均动脉压均呈正相关关系（r=0.311，P=0.001；r =0.245，P=0.011；r=0.308，P=0.001；r=0.203，P=0.037；r =0.219，P=0.024），复氧速率与患者夜间收缩压、舒张压、平均动脉压及白天舒张压和平均动脉压均呈正相关关系（r=0.327，P=0.001；r=0.288，P=0.003；r=0.343，P=0.000；r=0.250，P=0.01；r=0.259，P=0.007）；氧降速率和复氧速率均与OSA患者NBPF呈正相关关系（r=0.595，P<0.01；r=0.646，P<0.01）。

结论

OSA患者间歇性氧降和复氧的损害与其昼夜血压升高有直接关联，氧降与复氧速率的变化是导致OSA患者NBPF的重要因素。

关键词: 氧降速率, 复氧速率, 阻塞性睡眠呼吸暂停, 高血压

Abstract: Objective

To investigate the effect of the speeds of deoxygenation and reoxygenation on the diurnal and nocturnal blood pressure in the obstructive sleep apnea（OSA） patients，and to clarify their mechanisms.

Methods

The information of overnight polysomnography parameters of 106 OSA patients were collected，including sleep parameters and respiratory event parameters，as well as non-invasive multi-point continuous blood pressure monitoring during wakefulness and sleep stages on the monitoring day. The speed of deoxygenation was calculated by the ratio of the latitude value for oxygen desaturation and correspondent duration of desaturation. The reoxygenation speed was calculated similarly. The patients were divided into two groups based on the blood pressure values： OSA complicated with hypertension group （OSA+HT，n=59） and OSA without hypertension group（OSA－HT，n=47）. The differences in the speeds of deoxygenation and reoxygenation were analyzed between two groups.The correlations were respectively analyzed between the speeds of deoxygenation，reoxygenation， the diurnal and nocturnal blood pressure and the nocturnal blood pressure fluctuation（NBPF） for all the OSA patients.

Results

The deoxygenation speed and the reoxygenation speed in OSA + HT group was significantly higher than that in OSA－HT group （P<0.01）；the deoxygenation speed was positively correlated with the nocturnal systolic blood pressure， diastolic blood pressure， mean arterial pressure， diurnal diastolic blood pressure and mean arterial pressure （r=0.311，P=0.001；r=0.245， P= 0.011；r=0.308， P=0.001；r=0.203，P=0.037；r=0.219，P=0.024）， and the reoxygenation speed was positively correlated with the nocturnal systolic blood pressure， diastolic blood pressure， mean arterial pressure，diurnal diastolic blood pressure and mean arterial pressure （r=0.327，P=0.001；r=0.288，P=0.003；r=0.343，P=0.000；r=0.250，P=0.01；r=0.259，P=0.007）； there was a positive correlation between both of the deoxygenation speed and the reoxygenation speed and NBPF（r=0.595，P<0.01；r=0.646， P=<0.01）.

Conclusion

The damage of deoxygenation and reoxygenation in the OSA patients is directly related to the increase of blood pressure both during wakefulness and sleep stages. The changes of deoxygenation and reoxygenation speeds are the important factors for NBPF in the OSA patients.

Key words: deoxygenation speed, reoxygenation speed, obstructive sleep apnea, hypertension

中图分类号:

R332

陈月,于蕾,兰晓馨,贾思琪,袁海波. 氧降和复氧速率对阻塞性睡眠呼吸暂停患者昼夜血压的影响[J]. 吉林大学学报(医学版), 2021, 47(4): 1008-1013.

Yue CHEN,Lei YU,Xiaoxin LAN,Siqi JIA,Haibo Yuan. Effects of deoxygenation and reoxygenation speeds on diurnal and nocturnal blood pressure in obstructive sleep apnea patients[J]. Journal of Jilin University(Medicine Edition), 2021, 47(4): 1008-1013.

图/表 4

表1

表2

表3

图1

参考文献 28

1	SATEIA M J. International classification of sleep disorders-third edition： highlights and modifications［J］. Chest， 2014， 146（5）：1387-1394.
2	GOTTLIEB D J， PUNJABI N M. Diagnosis and management of obstructive sleep apnea： a review［J］. JAMA， 2020， 323（14）： 1389-1400.
3	AYAS N T， TAYLOR C M， LAHER I. Cardiovascular consequences of obstructive sleep apnea［J］. Curr Opin Cardiol， 2016， 31（6）： 599-605.
4	MARIN J M， AGUSTI A， VILLAR I， et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension［J］. JAMA， 2012， 307（20）：2169-2176.
5	SALMAN L A， SHULMAN R， COHEN J B. Obstructive sleep apnea， hypertension， and cardiovascular risk： epidemiology， pathophysiology， and management［J］. Curr Cardiol Rep， 2020， 22（2）：6.
6	CARNETHON M R， JOHNSON D A. Sleep and resistant hypertension［J］. Curr Hypertens Rep， 2019， 21（5）：34.
7	TAM W， NG S S， TO K W， et al. The interaction between hypertension and obstructive sleep apnea on subjective daytime sleepiness［J］. J Clin Hypertens （Greenwich）， 2019， 21（3）：390-396.
8	LLOBERES P， LOZANO L， SAMPOL G， et al. Obstructive sleep apnoea and 24 h blood pressure in patients with resistant hypertension［J］. J Sleep Res， 2010， 19（4）：597-602.
9	GONZAGA C C， GADDAM K K， AHMED M I， et al. Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension［J］.J Clin Sleep Med，2010，6（4）：363-368.
10	MUXFELDT E S， MARGALLO V S， GUIMARÃES G M， et al. Prevalence and associated factors of obstructive sleep apnea in patients with resistant hypertension［J］.Am J Hypertens，2014，27（8）：1069-1078.
11	AZARBARZIN A， SANDS S A， STONE K L， et al. The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality： the osteoporotic fractures in men study and the sleep heart health study［J］. Eur Heart J， 2019，40（14）：1149-1157.
12	SMITH L A， DAWES P J， GALLAND B C. The use of pulse transit time in pediatric sleep studies： a systematic review［J］. Sleep Med Rev， 2018， 37： 4-13.
13	WIBMER T， DOERING K， KROPF-SANCHEN C， et al. Pulse transit time and blood pressure during cardiopulmonary exercise tests［J］. Physiol Res， 2014， 63（3）：287-296.
14	VLAHANDONIS A， BIGGS S N， NIXON G M， et al. Pulse transit time as a surrogate measure of changes in systolic arterial pressure in children during sleep［J］. J Sleep Res， 2014， 23（4）：406-413.
15	PICARD F， PANAGIOTIDOU P， WEINIG L， et al. Effect of CPAP therapy on nocturnal blood pressure fluctuations， nocturnal blood pressure， and arterial stiffness in patients with coexisting cardiovascular diseases and obstructive sleep apnea［J］. Sleep Breath， 2021，25（1）：151-161.
16	ARNAUD C， BOCHATON T， PÉPIN J L， et al. Obstructive sleep apnoea and cardiovascular consequences： Pathophysiological mechanisms［J］. Arch Cardiovasc Dis， 2020， 113（5）： 350-358.
17	CHOBANIAN A V， BAKRIS G L， BLACK H R， et al. The seventh report of the joint national committee on prevention， detection， evaluation， and treatment of high blood pressure： the JNC 7 report［J］. JAMA， 2003， 289（19）： 2560-2572.
18	PEDROSA R P， DRAGER L F， GONZAGA C C，et al.Obstructive sleep apnea the most common secondary cause of hypertension associated with resistant hypertension［J］. Hypertension， 2011， 58（5）：811-817.
19	PATEL A R， PATEL A R， SINGH S， et al. The association of obstructive sleep apnea and hypertension［J］. Cureus， 2019， 11（6）：e4858.
20	MANSUKHANI M P， KOLLA B P， SOMERS V K. Hypertension and cognitive decline： implications of obstructive sleep apnea［J］.Front Cardiovasc Med，2019，6：96.
21	TKACOVA R， MCNICHOLAS W T， JAVORSKY M，et al. Nocturnal intermittent hypoxia predicts prevalent hypertension in the European Sleep Apnoea Database cohort study［J］. Eur Respir J， 2014， 44（4）：931-941.
22	SASAKI N， NAGAI M， MIZUNO H， et al. Associations between characteristics of obstructive sleep apnea and nocturnal blood pressure surge［J］. Hypertension， 2018， 72（5）： 1133-1140.
23	LABARCA G， GOWER J， LAMPERTI L， et al. Chronic intermittent hypoxia in obstructive sleep apnea： a narrative review from pathophysiological pathways to a precision clinical approach［J］.Sleep Breath，2020，24（2）：751-760.
24	TURNBULL C D. Intermittent hypoxia， cardiovascular disease and obstructive sleep apnoea［J］. J Thorac Dis， 2018， 10（）： S33-S39.
25	YAMAUCHI M， KIMURA H. Oxidative stress in obstructive sleep apnea： putative pathways to the cardiovascular complications［J］. Antioxid Redox Signal， 2008， 10（4）：755-768.
26	CARPAGNANO G E， KHARITONOV S A， RESTA O，et al. 8-Isoprostane， a marker of oxidative stress， is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy［J］. Chest， 2003， 124（4）：1386-1392.
27	刘雪，蒋军广，宋卫卫，等. 阻塞性睡眠呼吸暂停低通气综合征胰岛素抵抗的危险因素分析［J］. 郑州大学学报（医学版）， 2020，55（5）： 716-719.
28	VENKATARAMAN S， VUNGARALA S， COVASSIN N， et al. Sleep apnea， hypertension and the sympathetic nervous system in the adult population［J］. J Clin Med， 2020， 9（2）： 591.

Group	n	Age(year)	Gender (male/female)	BMI(kg·m^－2)	TST(t/min)	N1 (η/%)	N2 (η/%)
OSA－HT	47	41±10	41/6	28.08±3.93	343.97±86.75	32.8(20.9－55.2)	35.20±9.44
OSA+HT	59	39±8	57/2	31.43±4.73	354.38±93.64	58.0(48.6－62.3)	30.66±8.02
t/Z		1.187	1.827	－3.991	－0.592	－4.496	2.627
P		0.238	0.071	<0.01	0.558	<0.01	0.010
Group	n	N3 (η/%)	REM(η/%)	AHI(events/h)	SpO₂ nadir(η/%)	AI (events/h)	NBPF(η/%)
OSA－HT	47	22.13±10.97	12.96±5.26	58.0(25.2－77.7)	79.04±9.52	75.89±24.96	46.50±32.68
OSA+HT	59	9.39±8.04	12.68±10.82	82.0(70.6－96.2)	67.68±9.99	93.65±47.69	81.30±41.41
t/Z		4.817	0.176	－4.445	5.976	－2.467	－4.812
P		<0.01	0.861	<0.01	<0.01	0.015	<0.01

Group	n	Deoxygenation speed	Reoxygenation speed
OSA－HT	47	0.33±0.16	0.71±0.52
OSA+HT	59	0.49±0.18	1.08±0.46
t		－4.633	－3.902
P		<0.01	<0.01

Hypoxia parameter	Blood pressure	r	P
Deoxygenation speed	SBP during wakefulness	0.166	0.089
	DBP during wakefulness	0.203	0.037
	MAP during wakefulness	0.219	0.024
	SBP during sleep	0.311	0.001
	DBP during sleep	0.245	0.011
	MAP during sleep	0.308	0.001
Reoxygenation speed	SBP during wakefulness	0.176	0.071
	DBP during wakefulness	0.250	0.010
	MAP during wakefulness	0.259	0.007
	SBP during sleep	0.327	0.001
	DBP during sleep	0.288	0.003
	MAP during sleep	0.343	0.000

[1]	嵇朋,郭向东,孙根,寇启星,屈雪萍,孙雅静,江利敏. Rho/ROCK信号通路在阻塞性睡眠呼吸暂停低通气综合征大鼠急性缺血性卒中发生中的作用[J]. 吉林大学学报(医学版), 2021, 47(5): 1178-1186.
[2]	薛静,刘志明,吴永锋,董凯峰,王庆丰,祖金美,张海静,骆彬,孔祥苓. 痰热清注射液对阻塞性睡眠呼吸暂停低通气综合征大鼠外周血T淋巴细胞亚群的影响[J]. 吉林大学学报(医学版), 2021, 47(1): 96-101.
[3]	王芃, 李挪, 黄山, 李铁男, 郎晓峰, 刘伟. 幕上高血压脑出血患者不同手术方式的临床疗效比较[J]. 吉林大学学报(医学版), 2019, 45(03): 667-672.
[4]	钱楚岳, 宋君莉, 刘乃萌, 孙珉丹. 利福平对高血压患者降压药物效果的影响1例报告及文献复习[J]. 吉林大学学报(医学版), 2019, 45(02): 418-421.
[5]	谢文杰, 龙海权, 宋代富, 区德锦, 江岚, 陈晞明, 黄炯华. 高血压左心室肥厚患者血浆中自噬相关蛋白9a的水平及其临床意义[J]. 吉林大学学报(医学版), 2018, 44(04): 786-790.
[6]	金润浩, 徐忠福, 李庆, 全贞玉, 韩春姬. 血压身高比在吉林省延吉市青少年高血压筛查中的应用[J]. 吉林大学学报(医学版), 2018, 44(03): 639-645.
[7]	蓝永洪, 饶朗毓, 杨智, 黄明媚, 牛海艳, 齐亚灵. 妊娠高血压综合征患者胎盘组织中HIF-1α和HSP70的表达及其意义[J]. 吉林大学学报(医学版), 2018, 44(02): 346-349.
[8]	王伟倩, 李佳, 王曦, 冯勇, 卢雅艳, 赵娟, 徐金操. 咽侧壁分层缝合联合软腭低温等离子消融治疗重度阻塞性睡眠呼吸暂停低通气综合征患者的疗效[J]. 吉林大学学报(医学版), 2017, 43(03): 630-634.
[9]	郝铮, 刘楠, 王路, 李东原, 赵丛海, 刘伟明, 陈卓, 张金男. 立体定向与简易定位颅内置管治疗中等量高血压脑出血患者临床效果比较[J]. 吉林大学学报(医学版), 2017, 43(01): 130-134.
[10]	周叶, 程云章, 黄敬垣. 高血压伴冠状动脉狭窄患者左心房功能实时三平面应变率成像特征及其意义[J]. 吉林大学学报(医学版), 2016, 42(05): 1019-1023.
[11]	赵桐荫, 褚运松, 赵惠子, 刘志明, 曹宁, 李忠民. 吉林省农村地区居民膳食模式与高血压关系的调查分析[J]. 吉林大学学报(医学版), 2016, 42(02): 400-404.
[12]	袁海波, 张征骄, 张艳秋, 彭丽萍, 华树成. 肥胖青少年阻塞性睡眠呼吸暂停综合征患者上气道临界压的变化及其临床意义[J]. 吉林大学学报(医学版), 2015, 41(05): 990-993.
[13]	徐丽斯, 何金婷, 莽靖, 王学菊, 王丽萍, 那万里, 邵延坤, 徐忠信. 以头痛为首发症状的嗜铬细胞瘤1例报告并文献复习[J]. 吉林大学学报(医学版), 2015, 41(05): 1027-1031.
[14]	陈国志, 张镜宇, 刘飞. 有氧运动对肥胖性高血压大鼠肾素-血管紧张素系统和心功能的改善作用[J]. 吉林大学学报(医学版), 2015, 41(03): 563-567.
[15]	蒋玲玲, 杨雪玲, 吕薇, 张越, 殷雨天, 王钰涵, 王瑞, 张鹏, 李波, 姚燕. HLA-DRB1基因多态性与原发性高血压发病的关联性分析[J]. 吉林大学学报(医学版), 2015, 41(03): 619-624.